Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immune response: the afferent arm

A A Czitrom1

  • 1University of Texas, Southwestern Medical Center, Medical City Dallas Hospital, Advanced Surgical Institutes, USA.

Clinical Orthopaedics and Related Research
|May 1, 1996
PubMed
Summary

Understanding T cell activation in afferent immunity relies on antigen-presenting cells. The indirect pathway is crucial for musculoskeletal grafts due to the lack of donor antigen-presenting cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T-B co-operation examined by 'counterfeit' systems using cell surface antigens.

Immunology today·2014
Same author

Biology of allografting.

The Orthopedic clinics of North America·1998
Same author

Freeze-dried cortical allografts.

Orthopedics·1998
Same author

Fresh osteochondral allografts for advanced giant cell tumors at the knee.

The Journal of arthroplasty·1994
Same author

[Fresh osteochondral transplants in the treatment of advanced giant cell tumors].

Der Orthopade·1993
Same author

Principles and techniques of tissue banking.

Instructional course lectures·1993

Area of Science:

  • Immunology
  • Cellular Biology
  • Transplantation Immunology

Background:

  • T lymphocyte activation is central to afferent immunity.
  • Antigen-presenting cells (APCs) activate T cells via peptide-MHC class II binding and costimulation.
  • Key costimulatory pathways involve B7 ligands (B7-1/B7-2) on APCs and CD28/CTLA-4 receptors on T cells.

Purpose of the Study:

  • To elucidate the mechanisms of T cell activation in afferent immunity.
  • To highlight the significance of direct and indirect alloantigen recognition pathways.
  • To investigate the specific challenges in musculoskeletal allograft immunity.

Main Methods:

  • Review of T cell signaling pathways, including T cell receptor-CD3 complex and costimulatory molecules.
  • Analysis of direct and indirect pathways of T cell activation by alloantigens.
  • Examination of APC function in the context of musculoskeletal grafts.

Main Results:

  • T cell activation requires antigen presentation and costimulation (Signal 1 and Signal 2).
  • Allogeneic T cell activation occurs via direct recognition of donor MHC or indirect recognition of processed donor antigens.
  • Musculoskeletal grafts are prone to the indirect pathway due to the absence of viable donor APCs.

Conclusions:

  • Understanding T cell activation mechanisms is key to afferent immunity.
  • The indirect pathway of alloantigen recognition is particularly relevant for musculoskeletal allografts.
  • Targeting these pathways may improve allograft survival in musculoskeletal transplantation.

Related Experiment Videos